 | Hot Topics Sessions |
 | Strategies for Commercialization Track |
 | Quality and Operations Track |
Accelerating Cell & Gene Therapy Adoption:
Proof of Concept to Standard of Care
 | Plenary and Satellite Sessions |
 | Translational Research |
 | Clinical Translation |
 | Commercialization |
TUESDAY MAY 26
07:00 – 17:00
FACT Cord Blood Inspection and Accreditation Workshop
16:00 – 19:00
ISCT 2020 Registration Open
WEDNESDAY MAY 27 - Pre-Conference Day
PRECONFERENCE TRACKS
MSC
CO-CHAIRS
Jacques Galipeau, MD
University of Wisconsin-Madison (US)
Mauro Krampera, MD
University of Verona (IT)
Luc Sensebe, MD, PhD
ISCT MSC Committee (FR)
13:00 – 14:30
MSC Manufacturing for Clinical Use
14:45 – 16:15
MSC-based Clinical Trials in Europe
Cell Processing
CO-CHAIRS
Ruud Hulspas, PhD
Cellular Technologies Bioconsulting, LLC (NL)
Mara Neal, SH(ASCP)MT, MS, MBA
Cook Biotech (US)
Vicki Antonenas, MSc
Westmead Hospital (AU)
Paul Wallace, PhD
Roswell Park Comprehensive Cancer Center (US)
08:30 – 10:00
Collection and Starting
Materials
10:15 – 11:45
Cell Selection & Gene Editing
13:00 – 14:30
Cell Activation and
Expansion
14:45 – 16:15
Product Characterization, just before product goes to patient
Global Regulatory Perspectives
CO-CHAIRS
Karen Nichols, Esq.
Magenta Therapeutics (US)
Dominic Wall, PhD, FFSc (RCPA)
Cell Therapies Pty Ltd, Peter MacCallum Cancer Centre (AU)
08:00 – 08:30
Regulatory Roundup
08:30 – 10:00
Sterility Controls –
Past, Present, Future
10:15 – 11:45
Issues related to product administration at the clinical site
13:00 – 14:30
Combination Products (Biologics/Devices)
14:45 – 16:15
Topic TBC
Investigators to Investors
(i to i)
CO-CHAIRS
Bill Milligan
Steminent Biotherapeutics (CA/TW)
Patrick Rivers
Aquilo Capital (US)
Program under development
ISCT-Cord
Blood Connect
In partnership with WMDA
CO-CHAIRS
Elizabeth J. Shpall, MD
MD Anderson Cancer Center (US)
Joanne Kurtzberg, MD
Carolina’s Cord Blood Bank Duke University Medical Center (US)
Ngaire Elwood, PhD
BMDI Cord Blood Bank and Murdoch Children’s Research Institute (AU)
08:30 – 10:00
Cord Blood Breaking News
10:15 – 11:45
Cord Blood Immunotherapy
13:00 – 14:30
Cord Tissue Derived MSCs
14:45 – 16:15
Cord Blood Derived Regenerative Medicine
Gene Therapy
CHAIR
Sandeep Soni, MD
Stanford University (US)
08:30 – 10:00
Lentiviral Gene Therapy Approaches
10:15 – 11:45
Advances in Gene Therapy Technologies & Applications Part I
13:00 – 14:30
CMC Requirements & Considerations
14:45 – 16:15
Advances in Gene Therapy Technologies & Applications Part II
ISCT-FACT Quality Bootcamp
Program under development
Corporate Symposia
16:30 – 18:30
Technology Symposium
16:30 – 18:30
Technology Symposium
19:00 – 19:30
President’s Welcome Address
John Rasko, AO, BSc(Med), MBBS(Hons), PhD
University of Sydney (AU)
ISCT President
Mario Capecchi, PhD
University of Utah (US)
2007 Nobel Laureate
(Physiology or Medicine)
Christian Chabannon, MD, PhD
Institut Paoli Calmettes (FR)
ISCT 2020 Co-Chair
Rachele Ciccocioppo, MD
University of Verona (IT)
ISCT 2020 Co-Chair
Ivan Martin, PhD
University Hospital Basel (CH)
ISCT 2020 Co-Chair
19:30 – 21:00
Exhibit Open House and Welcome Reception
Open to all registered delegates, enjoy a glass of wine, hors d’oeuvres, and the opportunity to mingle and network
with peers from all over the globe.
Make new connections and discover the latest innovations and services from our exhibitors.
Global Showcase Theatre (Exhibit Hall)
19:45 – 20:00
20:00 – 20:15
Sexton Biotechnologies
20:15 – 20:30 
THURSDAY MAY 28 - Day One Main Meeting
07:30 - 08:30
Hot Topics Session
Regenerative Medicine in Digestive Diseases: State of the Art, Open Needs and Next Steps
C0-CHAIRS
Basak E. Uygun, PhD
Massachusetts General Hospital and Harvard Medical School (US)
Giuseppe Orlando, MD, PhD
Wake Forest University School of Medicine (US)
SPEAKERS
Khalil N. Bitar, PhD
Wake Forest University School of Medicine (US)
Vincenzo Cardinale, MD, PhD
Sapienza University of Rome (IT)
Pedro Baptista, PharmD, PhD
Madrid University and Aragon Institute for Health Research (ES)
07:30 - 08:30
Hot Topics Session
Gene Edited and Engineered Cell Based
Therapeutics for Cancer
CO-CHAIRS
Khalid Shah, MS, PhD
Harvard Medical School (US)
Massimo Dominici, MD
University of Modena and Reggio Emilia (IT)
07:30 - 08:30
Corporate Session
Breakfast Tutorial Hosted by
08:30 – 10:30
Opening Remarks
ISCT Career Achievement Award Presentation
Presidential Plenary
Mastering Pluripotent Cells with Therapeutic Intent
CHAIR
John Rasko, AO, BSc(Med), MBBS(Hons), PhD
University of Sydney (AU)
Mario Capecchi, PhD
University of Utah (US)
2007 Nobel Laureate (Physiology or Medicine)
Keynote speaker sponsored by Cytotherapy, The official journal of the International Society for Cell & Gene Therapy
Marc Peschanski, MD, PhD
I-Stem (FR)
Rudolf Jaenisch, MD
Whitehead Institute and Massachusetts Institute of Technology (US)
Break
10:30 – 11:00
Coffee Break with Exhibits and Corporate Sessions
Global Showcase Theatre (Exhibit Hall)
10:30 – 10:45
10:45 – 11:00
11:00 - 12:15
Plenary Satellite 1a
iPSC for Cardiovascular Disease
CHAIR
Daniel J. Weiss, MD, PhD
University of Vermont (US)
SPEAKER
Massimiliano Gnecchi, MD, PhD
University of Pavia & IRCCS Policlinico San Matteo (IT)
Philippe Menasché, MD, PhD
University Paris Decartes (FR)
11:00 - 12:15
Plenary Satellite 2a
MSC Mechanism of Action
CHAIR
Jacques Galipeau, MD
University of Wisconsin-Madison (US)
SPEAKER
Karin Tarte, PharmD, PhD
UMR INSERM U1236, CHU Rennes, EFS Bretagne (FR)
11:00 - 12:15
OC Session
Gene Therapy for Globin Disorders
SPEAKER
Marina Cavazzana, MD, PhD
Assistance Publique – Hôpitaux de Paris (FR)
11:00 - 12:15
Strategies for Commercialization
Innovating Process Development for Sustainable Manufacturing
CHAIR
Dominic Clarke, PhD
HemaCare Corp. (US)
SPEAKERS
Denis Bedoret, PhD
Masthercell (BE)
Stuart Curbishly, PhD
Birmingham University NHS Trust (UK)
Ricardo Batista, PhD
Cellectis (FR)
11:00 - 12:15
Quality & Operations
Qualification, Regulation of Gene Editing Tools in Cell & Gene Therapy
CHAIR
Shirley Bartido, PhD, MBA
Cellectis (US)
SPEAKERS
Christopher Ballas, PhD
Innovative Cellular Therapeutics (US)
David R. Jones, MSc
MHRA (UK)
Stephan Reynier, MSc
Cellectis (FR)
Break
12:15 – 13:45
Lunch with Exhibits and Corporate Sessions
Lunch & Learn Session
(Lunch Provided)
12:30 – 13:30
Lunch & Learn Session
(Lunch Provided)
12:30 – 13:30
Global Showcase Theatre (Exhibit Hall)
12:30 – 12:45 
12:45 – 13:00 Cynata
13:00 – 13:15 
13:15 – 13:30 
13:45 – 15:15
Plenary
Mesenchymal Stromal Cells – Full Circle from Basic Research Insights to Clinical Trial Updates
CHAIR
Sowmya Viswanathan PhD
University Health Network Cell Therapy (CA)
Jacques Galipeau, MD
University of Wisconsin-Madison (US)
Halvard Bönig, MD, PhD
Johann-Wolfgang-Goethe University (DE)
Dominique Farge Bancel, MD
Paris Diderot University and Hopital Saint-Louis (FR)
Break
15:15 – 15:45
Coffee Break with Exhibits and Corporate Sessions
Global Showcase Theatre (Exhibit Hall)
15:15 – 15:30 
15:30 – 15:45 
15:45 - 17:00
Plenary Satellite 1b
iPSC Derived Organoids
15:45 - 17:00
Plenary Satellite 2b
Opportunities, Challenges and Tangible Progress in the Development of Efficacious Culture Expanded Cell Therapies for Musculoskeletal Disease
MODERATOR
George Muschler, MD
Cleveland Clinic (US)
SPEAKERS
Christian Jorgensen, MD, PhD
University Hospital Lapeyronie (FR)
Scott Rodeo, MD
The Hospital for Special Surgery (US)
Nicolas Piuzzi, MD
Cleveland Clinic (US)
15:45 - 17:00
OC Session
Success and Failure of Cell Therapy Clinical Trials for Acute and Chronic Lung Disease
CO-CHAIRS
Patricia R. M. Rocco, MD, PhD
Federal University of Rio de Janeiro (BR)
Claudia Dos Santos, MD
University of Toronto (CA)
SPEAKER
Patricia R. M. Rocco, MD, PhD
Federal University of Rio de Janeiro (BR)
Bernard Thébaud, MD
Ottawa Hospital Research Institute (CA)
Anthony Ting, PhD
Athersys, Inc. (US)
Daniel J. Weiss, MD, PhD
University of Vermont (US)
John Laffey, MD, MA, FCAI, FJFICMI
NUI Galway (IR)
15:45 - 17:00
Strategies for Commercialization
Raising Capital for CGT Industralization
CHAIR
Patrick Rivers, MBA
Aquilo Capital (US)
SPEAKER
Jak Knowles, MD
Leaps by Bayer (US)
Mark L. Bonyhadi, PhD
Qiming Venture Partners (US)
Sara Núñez-Garcia, PhD, MBA
Roivant Sciences (SUI)
15:45 - 17:00
Quality & Operations
Manufacturing Process Validation – Considerations for Validation of Autologous Products
CHAIR
Emily Hopewell, PhD
Indiana University School of Medicine (US)
SPEAKERS
Antonio Ruiz-Garcia, MPharm
Hospital Universitario Virgen de las Nieves (SP)
Aisha Khan, MSc, MBA
University of Miami (US)
Corey Smith, PhD
QIMR Berghofer (AU)
Corporate Sessions
17:00 – 19:00
Therapeutic Symposium
17:30 – 18:30
Technology Spotlight
Posters & Abstract Presentations
Poster Hall
18:00 – 19:30
Poster Session
Global Showcase Theatre (Exhibit Hall)
18:00 – 18:30
Abstract Elevator Pitch Session 1
FRIDAY MAY 29 - Day Two Main Meeting
07:30 - 08:30
Hot Topics Session
Long-Term Follow-up, Accreditation and Registries for
CAR-T Therapy (Joint Session with EBMT)
07:30 - 08:30
Hot Topics Session
Veterinary Medicine
CHAIR
Stéphane Maddens, PharmD, PhD, MBA
Vetiobank (FR)
SPEAKER
Nathalie Saulnier, PhD
Vetbiobank (FR)
Antonio J. Villatoro, DVM, PhD, MBA
ImmuneStem (SP)
07:30 - 08:30
Corporate Session
Breakfast Tutorial Hosted by
08:45 – 10:15
Plenary
Advances and Emerging Technologies in Immune-Mediated Cancer Treatments
CO-CHAIR
Bruce Levine, PhD
University of Pennsylvania (US)
CO-CHAIR
Christian Chabannon, MD, PhD
Institut Paoli Calmettes (FR)
Marcela Maus, MD, PhD
Massachusetts General Hospital and Harvard Medical School (US)
Michael Hudecek, MD
University of Würzburg (DE)
Katy Rezvani, MD, PhD
MD Anderson Cancer Center (US)
Break
10:15 – 10:45
Coffee Break with Exhibits and Corporate Sessions
Global Showcase Theatre (Exhibit Hall)
10:15 – 10:30
10:30 – 10:45 
10:45 - 12:15
Plenary Satellite 3a
Immunotherapy Oral Abstracts
10:45 - 12:15
Plenary Satellite 4a
Industrializing Clinical Delivery
SPEAKERS
Jacqueline Barry, PhD
Cell and Gene Therapy Catapult (UK)
Aaron Dulgar-Tulloch, PhD
GE Healthcare (CA)
Gil Van Bokkelen, PhD
Athersys, Inc. (US)
10:45 - 12:15
OC Session
Imaging Cellular Therapeutics
(Joint Session with HESI CT-TRACS)
CHAIR
Brooke Helfer, PhD
Celsense Inc. (US)
SPEAKERS
Bettina Weigelin, PhD
Eberhard Karls University of Tübingen (DE)
Vidya Gopalakrishnan, PhD, MD
Anderson Cancer Center (US)
Jane Sosabowski, PhD
Barts Cancer Institute, Queen Mary University of London (UK)
10:45 - 12:15
Workshop
ISCT Presidential Task Force Session
SPEAKERS
Massimo Dominici, MD
University Hospital of Modena & Reggio Emilia – Modena Policlinic (IT)
Aaron Levine, PhD, Mphil
Georgia Tech (US)
Eva Rohde, Univ. Prof. Dr.
Department of Transfusion Medicine SALK (AT)
10:45 - 12:15
Strategies for Commercialization
Can we industrialize CAR T therapies? The practical challenges in achieving wide-spread patient access
CHAIR
Bill Milligan
Steminent Biotherapies (US/TW)
SPEAKERS
Gunther Busam, RPh, PhD
Celgene (CH)
Elizabeth Hexner, MD
University of Pennsylvania (US)
Wen Bo Wang, PhD
Fate Therapeutics (US)
Suma Rao, PhD
Allogene Therapeutics (US)
10:45 - 12:15
Quality & Operations
Regulatory CMC Considerations of ATMPs
CHAIR
Paula Salmikangas, PhD
NDA Advisory Services Ltd. (FI)
SPEAKERS
Christopher Bravery, PhD
Consulting on Advanced Biologicals Ltd (UK)
Shinichi Noda, PhD
Pharmaceuticals and Medical Devices Agency (PMDA) (JP)
Rocio Salvador-Roldan
European Commission (BE)
Break
12:15 – 13:45
Lunch with Exhibits and Corporate Sessions
Lunch & Learn Session
(Lunch Provided)
12:30 – 13:30
Lunch & Learn Session
(Lunch Provided)
12:30 – 13:30
Global Showcase Theatre (Exhibit Hall)
12:30 – 12:45
12:45 – 13:00 
13:00 – 13:15 Xcell Therapeutics
13:15 – 13:30 
13:45 – 15:15
Plenary
Is Big Pharma ready for industrial scale Cell and Gene Therapy?
CHAIR
Anthony Ting, PhD
Athersys (US)
Emanuele Ostuni, PhD
Novartis Oncology (CH)
Angela Krackhardt, MD
Technical University of Munich (DE)
Alberto Santagostino, MBA
Lonza (CH)
Break
15:15 – 15:45
Coffee Break with Exhibits and Corporate Sessions
Global Showcase Theatre (Exhibit Hall)
15:15 – 15:30
Cell-Easy
15:30 – 15:45 
15:45 - 17:00
Plenary Satellite 3b
CAR-T for Solid Tumors
SPEAKER
Vivek K. Narayan, MD, MS
University of Pennsylvania (US)
15:45 - 17:00
Plenary Satellite 4b
Industrializing administration setting
CHAIR
Julie Murrell, PhD
MilliporeSigma (US)
SPEAKERS
Christopher Herbert, PhD
Leeds Teaching Hospitals NHS Trust (UK)
Anne Black
NHS Specialist Pharmacy Service (UK)
Christoph Demmerle
Novartis (DE)
15:45 - 17:00
Workshop
ISCT Chief Scientific Officer Abstract Showcase
15:45 - 17:00
Workshop
Early Stage Professionals Session
15:45 - 17:00
Strategies for Commercialization
Best practices for funding CGT startups from academia
CHAIR
Patrick Rivers, MBA
Aquilo Capital, (US)
SPEAKERS
Mike Milone, MD, PhD
Cabaletta Bio (US)
Patrick Hanley, PhD
Children’s National Medical Center (US)
15:45 - 17:00
Quality & Operations
Starting & Raw Material Selection for ATMP Manufacturing
CHAIR
Gloria Carmona, MPharm
Andalusian Network for Design and Translation of Advanced Therapies (ES)
SPEAKERS
Craig Spalding, MBA
Scottish National Blood Transfusion Service (UK)
Rosaria Giordano, MD
Fondazione IRCCS Ca’ Granda – Ospedale Maggiore Policlinico (IT)
Daniela Bischof, PhD
Indiana University School of Medicine (US)
Gerhard Bauer, PhD
University of California Davis Institute for Regenerative Cures (US)
Posters & Abstract Presentations
Poster Hall
18:00 – 19:30
Poster Session
Global Showcase Theatre (Exhibit Hall)
18:00 – 18:30
Abstract Elevator Pitch Session 1
SATURDAY MAY 30 - Day Three Main Meeting
08:00 - 09:00
Hot Topics Session
The spleen plays a critical role in modulating therapeutic outcomes following administration of cellular therapies in acute treatment settings
CHAIR
Robert (Willie) Mays, PhD
Athersys, Inc. (US)
SPEAKER
Richard Maziarz, MD
Oregon Health & Science University (US)
08:00 - 09:00
Hot Topics Session
Safety Matters for Regenerated Tissues
(Joint Session with TERMIS EU)
CO-CHAIRS
Ineke Slaper, Cortenbach, PhD
ICCBBA (NL)
Marina Marechal, PhD
KU Leuben (BE)
SPEAKERS
Ineke Slaper, Cortenbach, PhD
ICCBBA (NL)
Marina Marechal, PhD
KU Leuben (BE)
Julie Allickson, PhD
Wake Forest Institute for Regenerative Medicine (US)
08:00 - 09:00
Strategies for Commercialization
Providing effective cellular therapies in the face of commercialization – meeting patients’ needs and expectations
CHAIR
Gerhard Bauer, PhD
University of California, Davis Institute for Regenerative Cures (US)
SPEAKERS
Kathryn Rodden, BSc
QEHB NHS Foundation Trust (UK)
Mohamed Abou-El-Enein, MD, PhD
Charité – Universitätsmedizin Berlin (DE)
Mark Yarborough, PhD
University of California, Davis (US)
08:00 - 09:00
Quality & Operations
Characterization of Active Substance and Comparability
CHAIR
Rosemarie Bell, B.App.Sc Micro/Biochem MASM
Q-Gen Cell Therapeutics QIMR Berghofer Medical Research Institute (AU)
SPEAKERS
Mehrshid Alai-Safer, PhD
Kite Pharmaceuticals (US)
Mohamed Heidaran, PhD
Parexel International (US)
Krishnendu Roy, PhD
Georgia Institute of Technology (US)
CHAIR
Sandeep Soni, MD
Stanford University (US)
Donald Kohn, MD
University of California Los Angeles (US)
Paula Rio, PhD
Centro de Investigaciones Energéticas
Medioambientales y Tecnológicas (CIEMAT) (SP)
Carlos Fonck, PhD
DABT, BioMarin Pharmaceuticals Inc. (US)
10:45 – 11:00
Coffee Break
11:00 - 12:00
Plenary Satellite 5a
Gene Therapy Clinical Trials
11:00 - 12:00
Plenary Satellite 6a
EV Technical Session
CHAIR
Clotilde Thèry, PhD
Institut Curie, INSERM (FR)
SPEAKER
An Hendrix, PhD
Ghent University (BE)
11:00 - 12:00
Workshop
Late Breaking Oral Abstracts
11:00 - 12:00
Strategies for Commercialization
Clinical experience in regenerative medicine and tissue engineering, the next wave of advanced therapies
CHAIR
Julie Allickson, PhD
Wake Forest Institute for Regenerative Medicine (US)
SPEAKERS
Petter Björquist, PhD
VERIGRAFT AB (SE)
Martin Birchall, MD
University College London (UK)
Heather Prichard, PhD
Humacyte (US)
11:00 - 12:00
Quality & Operations
Analytical Tools and Method Development
CHAIR
Gerry McKiernan
Cell Therapies Pty Ltd (AU)
SPEAKER
Sophie Paczensy, MD, PhD
Indiana University School of Medicine (US)
David M. Barrett, MD, PhD
Children’s Hospital of Philadelphia (US)
12:00 – 13:30
Lunch
12:15 – 13:15
ISCT Annual General Business Meeting
(All Members Invited)
13:30 – 15:00
Plenary
Basics and translational potential of extracellular vesicles including exosomes
CHAIR
Bernd Giebel, PhD
University Hospital Essen
Institute for Transfusion (DE)
Clotilde Théry, PhD
Institut Curie, INSERM (FR)
Sai-Kiang Lim, PhD
Institute of Medical Biology, A*STAR (SG)
Rebecca Lim, PhD
Monash University (AU)
15:00 – 15:15
Coffee Break
15:15 - 16:30
Plenary Satellite 5b
Ex-Vivo Stem Cell Based Clinical Trials
SPEAKER
Sandeep Soni, MD,
Stanford University (US)
15:15 - 16:30
Plenary Satellite 6b
ISCT-ISEV Joint Session: MSC-EVs
SPEAKER
Mario Gimona, PhD
Paracelsus Medical University (AT)
15:15 - 16:30
Workshop
Early Stage Professionals Session
15:15 - 16:30
Strategies for Commercialization
Fast Track Regulations
CHAIR
Siofradh McMahon, MSc
CCRM (CA)
SPEAKER
Katy Spink, PhD
Dark Horse Consulting Group (US)
Eric Faulkner, MPH
Evidera (US)
15:15 - 16:30
Quality & Operations
GMP Manufacturing Challenges
CHAIR
Shiraz Ziya, PhD, FRSA
Sartorius Stedim Biotech Ltd (UK)
SPEAKER
Angela Osborne, PhD
eXmoor pharma concepts ltd (UK)
Linda Kelley, PhD
Moffitt Cancer Center (US)
Suzanne Farid PhD, CEng, FIChemE
Dept. of Biochemical Engineering, UCL (UK)
Sarah Nikiforow MD, PhD
Dana-Farber Cancer Institute (US)